Nivolumab in combination with cabozantinib for metastatic triple-negative breast cancer: a phase II and biomarker study

por Barroso-Sousa, Romualdo, Keenan, Tanya E., Li, Tianyu, Tayob, Nabihah, Trippa, Lorenzo, Pastorello, Ricardo G., Richardson III, Edward T., Dillon, Deborah, Amoozgar, Zohreh, Overmoyer, Beth, Schnitt, Stuart J., Winer, Eric P., Mittendorf, Elizabeth A., Van Allen, Eliezer, Duda, Dan G., Tolaney, Sara M.
Publicado 2021